What treatment option should be added to reduce TG levels in a patient with a history of acute pancreatitis and TG concentration exceeding 1000 mg/dL?

What treatment option should be added to reduce TG levels in a patient with a history of acute pancreatitis and TG concentration exceeding 1000 mg/dL?

• A. Niacin
• B. Omega-3 fatty acids
• C. Fibrate
• D. Increased statin dose

Answer: (B)

Omega-3 fatty acids are the recommended treatment option for patients with triglyceride (TG) levels exceeding 1000 mg/dL, particularly in the context of a history of acute pancreatitis. Omega-3 fatty acids, such as those found in prescription products like icosapent ethyl, are effective in lowering TG concentrations and are often used specifically for the management of hypertriglyceridemia.

In patients with very high triglycerides, the risk of acute pancreatitis can increase, and lowering TG levels is critical to prevent such complications. Omega-3 fatty acids not only effectively reduce triglyceride levels by decreasing hepatic production of triglyceride-rich lipoproteins, but they also have a favorable safety profile. This makes them particularly advantageous when considering options for hypertriglyceridemia management in patients with a history of pancreatitis.

In contrast, niacin can lower triglyceride levels but carries a risk of side effects such as flushing and hepatotoxicity. Fibrates are another option for lowering triglycerides; however, they are not first-line for patients with a history of pancreatitis due to the potential for adverse effects, especially when used with statins, which increases the risk of myopathy. Increasing the statin dose may be